search Search
search Search
  1. hcp portal
  2. myloop

myLoop

myLoop

Whether you want to deepen your knowledge of myLoop or are just getting started, learn how to customise myLoop with CamAPS FX and it's unique features to make a difference in the lives of people living with type 1 diabetes.

YpsoPump Explorer app

YpsoPump Explorer App

For YpsoPump virtual pump access - click here for the YpsoPump Explorer App

Read the guide

Download

Get to know the CamAPS FX app!
arrow-right Download here

Download the app and select a virtual pump and CGM system to get started!

Related Content

You may also be interested in ...

information
Product Information
Powered by CamAPS FX, myLoop is indicated for children aged one year and older and for use in pregnancy.
Learn More
phone
Events
Stay informed. Follow us for the latest insights on the most rapidly evolving areas of diabetes technology and treatments.
Follow us
download
Resources
Explore factsheets, downloads, and scientific publications to support your practice and advance patient care.
Explore more

DisclaimerThe product images are for illustrative purposes only.mylife and YpsoPump are registered trademarks of Ypsomed AG in several countries.CamAPS is a registered trademark of CamDiab Ltd.Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. in the United States and/or other countries.The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ypsomed is under license.Other trademarks are the property of their respective owners.

myLoop with Freestyle Libre3/Libre 3 Plus: The innovations described are available in selected countries and expanding to further countries soon. Expansion is contingent upon local regulatory approval.Insulin pumps and Automated Insulin Delivery (AID) systems can improve glucose management but do not remove the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g., infusion-set failure, occlusion, empty reservoir, or device malfunction) can rapidly lead to ketosis and DKA, even if glucose levels are not markedly elevated.Healthcare professionals should ensure that users understand the risk of DKA associated with pump and AID therapy, particularly in situations where insulin delivery may be interrupted. Users should be trained to recognise and troubleshoot delivery issues promptly, know when and how to check for ketones and seek urgent medical assistance. Advise to always keep a reliable backup method of insulin delivery available.This information is provided for general educational purposes and is intended for healthcare professionals. It does not replace individual clinical judgement or patient-specific medical advice.

information
For safety information on mentioned products, see

link mylife-diabetescare.com/safety

Ypsomed Ltd.1 Park CourtRiccall RoadEscrickYO19 6EDUnited Kingdom

Free Call 0344 856 7820 (UK)Free Call 1800 911 522 (ROI)F +44 844 507 0443

info@ypsomed.co.uk

Trademarks and images

mylife, YpsoPump, YpsoPod and Orbit are registered trademarks of Ypsomed Diabetes Care AG in several countries. Other trademarks are the property of their respective owners. The product images are for illustrative purposes only.

© 2026 mylife Diabetes Care AG